Abstract:Prospective simulations of human pharmacokinetic (PK) parameters and plasma concentration-time curves using in vitro in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) models are becoming a vital part of the drug discovery and development process. This paper presents a strategy to deliver prospective simulations in support of clinical candidate nomination. A three stage approach of input parameter evaluation, model selection and multiple scenario simulation is utilized to predict the key components influencing human PK; absorption, distribution and clearance. The Simcyp® simulator is used to illustrate the approach and four compounds are presented as case studies. In general, the prospective predictions captured the observed clinical data well. Predicted C(max) was within 2-fold of observed data for all compounds and AUC was within 2-fold for all compounds following a single dose and three out of four compounds following multiple doses. Similarly, t(max) was within 2-fold of observed data for all compounds. However, C(last) was less accurately captured with two of the four compounds predicting C(last) within 2-fold of observed data following a single dose. The trend in results was towards overestimation of AUC and C(last) , this was particularly apparent for compound 2 for which clearance was likely underestimated via IVIVE. The prospective approach to simulating human PK using IVIVE and PBPK modeling outlined here attempts to utilize all available in silico, in vitro and in vivo preclinical data in order to determine the most appropriate assumptions to use in prospective predictions of absorption, distribution and clearance to aid clinical candidate nomination.

Pharmacokinetic model for extravascular administration based on uncertain differential equation

Pharmacokinetics with Intravenous Infusion of Two-Compartment Model Based on Liu Process

Study of Digoxin Concentrations Using Uncertain Differential Equations

A linear uncertain pharmacokinetic model driven by Liu process

Michaelis–Menten pharmacokinetics based on uncertain differential equations

Application of Ivive and Pbpk Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies

Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence

Reinforcement Learning Based Model Selection and Parameter Estimation for Pharmacokinetic Analysis in Drug Selection.

A New Method for the Estimation of Absorption Rate Constant in Two-compartment Model by Extravascular Administration.

Mathematical Modeling of Recursive Drug Delivery with Diffusion, Equilibrium, and Convection Coupling

Using a State-Bounding Observer to Predict the Guaranteed Limits of Drug Amounts in Rats after Oral Administration Based on an Uncertain Pharmacokinetic Model

Probabilistic analysis of a class of compartmental models formulated by random differential equations

Parameter Estimation of Population Pharmacokinetic Models with Stochastic Differential Equations: Implementation of an Estimation Algorithm

Modeling and administration scheduling of fractional-order pharmacokinetic systems

On separation of time scales in pharmacokinetics

A novel approach of modeling pharmacokinetics and pharmacokinetics-pharmacodynamics for the intravenous nano drug delivery system

Density-based Monte Carlo filter and its applications in estimation of unobservable variables and pharmacokinetic parameters

Modeling and Prediction Using Stochastic Differential Equations

Uncertain differential equation based accelerated degradation modeling

Advances in Modeling Approaches for Oral Drug Delivery: Artificial Intelligence, Physiologically-Based Pharmacokinetics, and First-Principles Models

Overcoming the shortcomings of the extended-clearance concept: a framework for developing a physiologically-based pharmacokinetic (PBPK) model to select drug candidates involving transporter-mediated clearance